# Large in-plane optical anisotropy in epitaxial CrN(113) films

Preprint · Duc V. Dinh, Frank Peiris, Oliver Brandt

- Archive id: arxiv:2610.21856
- Published: 2026-10-15
- arXiv: https://arxiv.org/abs/2610.21856
- Citations: 0
- Source URL: https://arxiv.org/abs/2610.21856
- PDF: https://arxiv.org/pdf/2610.21856
- Provenance: arxiv

## Abstract

CrN, a transition-metal nitride crystallizing in the cubic rocksalt structure, exhibits a unique combination of mechanical robustness, semiconducting behavior, and thermoelectric functionality. To date, however, CrN has been synthesized primarily as polycrystalline material or as epitaxial films grown along high-symmetry orientations such as (001) and (111). Here, we prepare epitaxial CrN(113) films on AlN(11\\bar{2}2) templates by plasma-assisted molecular beam epitaxy. The low-symmetry interface and highly direction dependent lattice mismatch are expected to modify the physical properties of CrN relative to the bulk material. Indeed, variable-angle spectroscopic ellipsometry in the photon-energy range from 1.25 to 5 eV reveals a surprisingly strong polarization dependence of the optical response despite the nearly strain-free cubic crystal structure of the films. The pseudo-optical constants n and k differ by more than 10% for orthogonal in-plane polarizations throughout the investigated spectral range. We evaluate possible origins of this effect and conclude that it most likely arises from anisotropic surface morphology of CrN(113), which creates a metasurface acting as a subwavelength grating in the strongly absorbing regime.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Metamaterials, Nanophotonics & Integrated Photonics](https://space-kitty.com/topics/metamaterials-photonics)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.